What Researchers Did
Researchers conducted a retrospective analysis of 91 ICU patients with necrotizing soft tissue infections treated with HBOT at a German university hospital from 2008 to 2017, examining mortality, complications, ICU time, and functional limitations.
What They Found
The study examined outcomes in the context of established treatment guidelines, assessing whether combining HBOT with standard care (surgery, antibiotics, intensive care) produced acceptable results. The authors aimed to contribute to a national case registry for NSTI-HBOT data.
What This Means for Canadian Patients
Necrotizing fasciitis carries up to 30-40% mortality in Canadian hospitals even with aggressive treatment. This large German cohort adds to the evidence base for adjunctive HBOT in NSTI. A similar Canadian registry would help determine whether HBOT should be standard of care in Canadian necrotizing infection management.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract for this retrospective study does not provide specific outcome data including mortality rates or complication rates, limiting the ability to assess the actual findings.